01 September 1997
Nadroparin calcium in the treatment of acute myocardial infarction
Adam M. Curyło, Kalina Kawecka-Jaszcz, Danuta Czarnecka, Janusz Grodecki, Ryszard Drożdż, Jerzy W. NaskalskiMed Sci Monit 1997; 3(5): CR700-703 :: ID: 501623
Abstract
The present study was undertaken to define the effects of streptokinase combined with nadroparin calcium (Fraxiparine) as compared with streptokinase combined with heparin in the treatment of myocardial infarction. The study population consisted of 86 patients with acute myocardial infarction randomized into a group given streptokinase and nadroparin calcium (45 patients) and a group treated with streptokinase and heparin (41 patients). The patients were evaluated with respect to the rate of enzyme changes, electrocardiographic and echocardiographic changes, the rate of reinfarctions, rhythm disorders, hemorrhagic complications and mortality. Patients treated with nadroparin calcium showed an earlier peak activity of CK, CKMB and myoglobin concentration than controls. In the same group there were also more patients with 50% reduction of the sum of ST segment elevations after 2 hours of therapy. Both groups did not differ in the peak activity of enzymes, the frequency of left ventricular thrombus, severe arrhythmias, reinfarctions and hemorrhagic complications. Ejection fraction was insignificantly higher in those treated with nadroparin calcium and mortality in the patients given heparin.The present results seem to indicate higher frequency of myocardial reperfusion in patients treated with streptokinase and nadroparin calcium than in those treated with streptokinase and heparin.
Keywords: thrombolysis, Streptokinase, Heparin, creatine kinase
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
14 Mar 2024 : Clinical Research
Renal Dysfunction Increases Risk of Adverse Cardiovascular Events in 5-Year Follow-Up Study of Intermediate...Med Sci Monit In Press; DOI: 10.12659/MSM.943956
15 Mar 2024 : Clinical Research
Impact of One-Lung Ventilation on Oxygenation and Ventilation Time in Thoracoscopic Heart Surgery: A Compar...Med Sci Monit In Press; DOI: 10.12659/MSM.943089
14 Mar 2024 : Clinical Research
Differential DHA and EPA Levels in Women with Preterm and Term Births: A Tertiary Hospital Study in IndonesiaMed Sci Monit In Press; DOI: 10.12659/MSM.943895
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952